2. One of the most exciting aspects of genetic engineering is to
design, develop, and produce proteins with improved
operating characteristics ( increased stability, improved
kinetics etc)
Besides sometimes creating even novel proteins.
The techniques such as site- directed mutagesis and gene
cloning are utilized for this purpose.
3. Increasing the stability and biological activity of proteins
By increasing the half lives or thermosatbility of enzyme/
protein their industrial applications or therapeutic uses can
be more appropriately met.
Some of the approaches for producing proteins with
enhanced stability are described below.
Addition of disulphide bonds:
Significant increase in the thermostability of enzymes is
observed by adding disulphide bonds should not interfere
with the normal enzyme function.
4. In general, the new protein with added difulphide bonds
does not readily unfold at high temp., and further it is
resistant to denaturation at non-physiological conditions (
high pH, presence of organic solvents).
These characteristics are particularly important for industrial
applications of certain enzymes.
E.g. T4 lysozyme:-
This an enzyme of bacteriophages t4.
Good success has been achieved in introducing disulphide
bonds in T4 lysozyme.
5. This was done by changing 2, 4, 6 amino acids to cysteine
residues to respectively form 1, 2, or 3 disulphide bonds.
T4 lysozyme with 3 disulphide bonds is very stable with good
biological activity.
E.g.-Xylanase:-
used in industry for mfg of paper from wood pulp.
Catalytically active at high temp.
Introduction of disulphide bonds make it thermostable ans
substantially improves its functional efficiency.
6. Changing asparagine to other amino acids:-
At high temp, the amino acids asparagine and also
glutamine are likely to undergo deamidation(releasing
ammonia) to respectively form aspartic acid and glutamic
acid.
These alterations are often associated with changes in the
protein folding and loss of biological activity.
E.g.triosephosphate isomerase:-
Dimeric enzy mes with identical subunits, each one having
asparagine residues which are termosensitive.
7. It is used to introduce threonine or isoleucine in place of
asparagine at position 14 & 78.
New enzyme found to be thermostable.
Reducing the free sulfhydryl groups:-
Sometimes, the presence of free sulfhydryl groups in more
numbers may be responsible for the low activity of the
protein.
In such case, the protein or enzyme stability and its activity
can be increased by reducuing the number of sulfhydryl
groups.
8. Human beta interferon:-
The antiviral activity of human beta interferon produced by
E.Coli by genetic engineering was found to be only 10 % of
the original glycosylated form.
Further IFN-B was found to exist as dimers & oligomers
which are almost inactive.
This problem was successfully overcome by replacing
cysteine residues by serine.
So it reduces free sulfhydryl groups.
By above process IFN-B with increased stability & good
biological activity can be produced.
9. Single amino acid changes:-
Some of the recombinant protiens can be improved in their
stability and biological activity by a second generation
variants. These have been frequently achieved by a single
amino acid change.
E.g. it inhibit action of neutrophile elastase( it damage lung
tissue leads to emphysema).
By binding with elastase α1 antitrypsin prevent its action
In this process cleavage between serine and methionine is
formed whcich make α1 Antitrypsin poor inhibitor.
10. Problem overcome by replace methionine at 358 positionby
valine.
New enzyme used in α1 Antitrypsin deficiency.
Insulin
In neutral solution is mostly present as a zinc-containing
hexamer
By inroducing single amino acid substitutions,insulin found
to be monomeric state with good stability and biological
activity.
11. Tissue plasminogen activator(tPA):
a. Tissue plasminogen activator is therapeutically used to
lyse the blood clots that cause myocardial infraction.
b. Due to its shorter half- life (around 5 min) ,tPA has to be
repeatedly administered.
c. By replacing asparagine residue (at position 120) with
glutamine ,the half -life of tPA can be substantially
d. This is due to the fact that glutamine is less glycosylated
then asparagine and this makes difference in the half-life of
tPA.
12. Hirudin:
a. Hirudin is protein secreated by leech salivary gland ,and is
strong thrombine inhibitor it acts as an anticoagulant
b. By replacing asparagine with lysine,the potency of hirudin
be increased several folds.
Dihydrofolatereductase:
a. The enzyme dihydrofolatereductase (DHFR) catalyse the
conversion of 7,8-dihdrofolate to 5,6,7,8-tetrahydrofolate .
b. The latter coenzyme is closely involoved in one carbon
metabolism,which ultimately results in the synthesis of nucleic
acids and amino acids.
13. c. The inhibition of DHFR will restrict the growth of tumor cells.
d. By employing size directed mutagenesis,by replacement of
glysine by alanine was found to produce DHFR which is
completely inactive.
T4 lysozyme:
a. Replacement of glycine by any other amino acid the protein
structure, in general decreases the stability.
b. On the other hand proline residues increase protein stability .
c. The T4 lysozyme substitution of glycine(at position 77) by
alanine and alanine (at position 82)by proline are found to
increase the enzyme stability.
14. Improving kinetic properties of enzymes:
a. It is possible to improve the functional activities of
enzyme by improving the kinetic properties through
oligonucleotides directed mutagenesis.
b. This is particularly required for enzymes with individual
and therapeutic applications.
Subtilisin:
a. Subtilisin is major industrial enzyme secreted by gram
positive bacteria .
b. Is is a serine protease very widely used as an enzyme
detergent.
15. The reason being that methionine line closed to active sides
get oxidized,making the enzyme inactive.
e. Logically replacement of methionine by others amino
acids will solved the problem
Modifying metal requirement of subtilisin :
I. The enzyme subtilisin binds to calcium and get stabilized
III. they bind to calcium and the enzyme becomes inactive.
IV. This problems can be solved by oligonucleiotides directed
mutagenesis .
16. Asparaginase:
a. This is an enzyme used in control of leukemia.
b. Intravenous administration of asparaginase cleaves
asaparagine to aspartate .
c. Thus,the asparaginase with a low Km value has to be
seleted for thearapeutic use in control of leukemia.
Tyrosilt-RNAsynthetase:
The enzyme tyrosil t-RNA synthetase has been modified
from Bacillus stearothermophilus with substrate binding i.e.
Km value. This enzyme catalyses two reactions to give
tyrosine t-RNA.
17. Tyrosin + ATP Tyrosyladenylate +PPi
Tyrosyladenylate +t-RNA Tyrosine t-RNA + AMP
Restriction endonuclease
There are 2500 restriction endonucleases are known. Most of the
enzyme recognize same sequence on DNA for action, only about
200 have different recognition site.
Types of restriction endonucleases
Frequent cutters- recognizes sequence of 4-6bp.
Rare cutters- recognizes sequence above4 8 bp.
Using protein engineering technique, restriction endonucleases
have been suitably modified to produce rare cutters.
18. Protein engineering by use of gene families
The recent development in protein engineering is DNA
shuffling(molecular breeding).
It can be applied to protein if belong to known protein
family.
Technique involve isolation of gene from each species, then
creation of hybrids in different combnation.
26 species were mixed to create a library while applying
approach to subtilisin.
04 were found improved properties.
19. Protein engineering through chemical modification
Chemical modification of proteins have increased the
stability of proteins to high temp. and organic solvents.
Mostly used cross linker is glutaraldehyde, which stabilizes
protein in solutions.
Certain proteins like insulin, hemoglobin ,
phosphofructokinase have been stabilized using
glutaraldehyde.
20. Protein engineering- ever expanding field
Techniques of protein engineering are rapidly expanding
offering newer developments of protein/ enzymes for
industrial and therapeutic purpose.
The challenge of biotechnologist specialized in protein
engineering is ‘how do I achieve the modification I wish to
make.’